Delivery Order SPE2DB20D9759-SPE2DB25FD5PX
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $17,574.41 to DMS Pharmaceutical Group Inc. on August 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, allowing...
- The Defense Logistics Agency awarded a $20,085.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 30, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This award carries an ultimate completion date of August 20, 2025, and will be performed in Park Ridge, Illinois. No set-aside designation was applied to this contract. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, was selected as the...
- The Defense Logistics Agency awarded a delivery order valued at $2,510.63 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management in surgical settings. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of August 21, 2025. This delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $25,106.30 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries an ultimate completion date of September 5, 2025, and involves no set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role...
- The Defense Logistics Agency awarded a delivery order valued at $8,234.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on August 28, 2025, with an ultimate completion date of September 19, 2025, was executed without a set-aside designation. The order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $25.1K delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 11, 2025, under a firm fixed-price arrangement. The work will be performed in Park Ridge, Illinois, where DMS...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at approximately $25.1K for EXPAREL 266 mg/20 mL vials. This award was issued as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. EXPAREL is...
- The Defense Logistics Agency awarded a $50,212.60 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and was awarded on August 5, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- SPE2DB20D9759Indefinite Delivery Contract
- SPE2DB20D9759-SPE2DB25FD5PXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials on August 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, will be fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the procurement of a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group, a registered pharmaceutical wholesaler since 2001, serves as a critical supplier in the federal pharmaceutical supply chain, providing both branded and generic medications, biologics, and medical consumables to military health systems. EXPAREL, a long-acting local anesthetic, represents the type of specialized pharmaceutical product routinely procured through this contract vehicle to support clinical operations at DoD medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 8/28/25 |